Table of Content


Introduction
Kidney Cancer - Overview
Kidney Cancer - Therapeutics Development
Kidney Cancer - Therapeutics Assessment
Kidney Cancer - Companies Involved in Therapeutics Development
Kidney Cancer - Drug Profiles
Kidney Cancer - Dormant Projects
Kidney Cancer - Discontinued Products
Kidney Cancer - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Kidney Cancer (Renal Cell Cancer), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Kidney Cancer (Renal Cell Cancer), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by 4D Pharma Plc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by 4SC AG, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Aadi Bioscience Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by AbbVie Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by ABL Bio Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Acepodia Biotech Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Acrotech Biopharma LLC, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Actuate Therapeutics Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Adaptimmune Therapeutics Plc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by ADC Therapeutics SA, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Adlai Nortye Biopharma Co Ltd, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Advenchen Laboratories LLC, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Affimed GmbH, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Affitech A/S, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Agenus Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by AIM ImmunoTech Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Akeso Inc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Alkermes Plc, H1 2020
Kidney Cancer (Renal Cell Cancer) - Pipeline by Alligator Bioscience AB, H1 2020